Clinical Trials Directory

Trials / Unknown

UnknownNCT05971654

Effect Of Azithromycin in Women at Risk of Preterm Labour

Effect Of Azithromycin On Pregnancy Prolongation In Women at Risk of Preterm Labour

Status
Unknown
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Beni-Suef University · Academic / Other
Sex
Female
Age
20 Years – 40 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to evaluate the benefit of the addition of azithromycin to standard treatments to prolong pregnancy in women having intact membranes and is at risk of or in preterm labour.

Detailed description

Study Design: Comparative controlled study. Study site : The study will be conducted at the department of Obstetrics and Gynecology at Beni-Suef University Hospital. Study period: The study will be conducted from 15th September 2022 till reaching the target number. Study Population The control group will include pregnant women, having intact membranes and are at risk of or in preterm labour, administrating the standard treatments for prolongation of pregnancy. The test group will involve pregnant women, having intact membranes and are at risk of or in preterm labour, administrating the standard treatments for prolongation of pregnancy plus prophylactic azithromycin.:500 mg PO once for 5 days every month. Sample size: The sample size was determined using G\*Power Version 3.1.9.2 \[computer software\] (Franz Faul, Kiel, Germany),Power analysis for a chi-square test was conducted in G-POWER to determine a sufficient sample size using an alpha error of probability of 0.05, power of 0.95, a medium effect size (w = 0.3) and 1 degree of freedom. Based on the aforementioned assumptions, the desired sample size is 145. By calculating 25% drop out, so the least total sample size in both groups will be 200 patients (95 patients in each group). Each patient will be subjected to: Thorough history taking and examination. Investigations: Complete blood picture (CBC), bleeding profile , kidney function tests and liver function tests will be done. Ultrasound: 2D Ultrasound assessing : It will be carried out in Gynecology and Obstetrics department in Beni-Suef University Hospital, ultrasonography criteria: Ultrasound biometry of the fetus is now the gold standard for assessing fetal growth. The measurements most commonly used are the biparietal diameter, head circumference, abdominal circumference and femur length

Conditions

Interventions

TypeNameDescription
DRUGazithromycinazithromycin.:500 mg PO once for 5 days every month

Timeline

Start date
2023-07-30
Primary completion
2023-09-30
Completion
2024-05-30
First posted
2023-08-02
Last updated
2023-08-02

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05971654. Inclusion in this directory is not an endorsement.